Biomarker modulation in a nonhuman rhesus primate model for ovarian cancer chemoprevention

Cancer Epidemiology Biomarkers and Prevention

Volumn 10, Issue 8, 2001, Pages 889-893

  Brewer, Molly ^a,b   Utzinger, Urs ^c   Satterfield, William ^a   Hill, Lori ^a   Gershenson, David ^a   Bast, Robert ^a   Wharton, J Taylor ^a   Richards Kortum, Rebecca ^c   Follen, Michele ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c The University of Texas at Austin   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ETHINYLESTRADIOL PLUS NORETHISTERONE; FENRETINIDE; FLAVINE ADENINE NUCLEOTIDE; MESTRANOL PLUS NORETHISTERONE; NICOTINAMIDE ADENINE DINUCLEOTIDE; ORAL CONTRACEPTIVE AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG MECHANISM; DRUG MIXTURE; DRUG TOLERABILITY; FEMALE; FLUORESCENCE SPECTROSCOPY; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALS; CHEMOPREVENTION; CONTRACEPTIVES, ORAL; DISEASE MODELS, ANIMAL; FEMALE; FENRETINIDE; MACACA MULATTA; OVARIAN NEOPLASMS; PHENOTYPE; SPECTROMETRY, FLUORESCENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 0034902134     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Prospective on ovarian cancer: Why prevent?
2. Strategies for Phase II cancer chemoprevention trials: Cervix, endometrium, and ovary
3. A Phase II chemoprevention trial design to identify surrogate endpoint biomarkers in breast cancer
4. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 U.S. Case-control studies. II. Invasive epithelial ovarian cancers in white women
5. Pooled analysis of 3 European case-control studies. III. Oral contraceptive use
6. Cancer, and Steroid Hormone Study. Oral contraceptive use and the risk of ovarian cancer
7. Epithelial ovarian cancer and combination oral contraceptives
8. A case-control study of oral contraceptive use and invasive epithelial ovarian cancer
9. Effect of progestin on the ovarian epithelium of macaques: Cancer prevention through apoptosis?
10. Reproductive biology
11. Reproductive, genetic, and dietary risk factors for ovarian cancer
12. Can fenretinamide protect women against ovarian cancer
13. Alterations of cellular characteristics of a human ovarian teratocarcinoma cell line after in vitro treatment with retinoids
14. Synergistic inhibition of ovarian cancer cell proliferation by TGFβ and retinoic acid (RA) derivatives
15. Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression
16. Light-induced fluorescence spectroscopy of adenomas, adenocarcinomas and non-neoplastic mucosa in human colon
17. Gastrointestinal tissue diagnosis by LIF spectroscopy at endoscopy
18. Autofluorescence of normal and malignant bronchial tissue
19. Detection of dysplasia and carcinoma in situ by ratio fluorometry
20. Metabolic heterogeneities in rapidly metabolizing tissues
21. Immunocytochemical localization of estradiol and progesterone receptors in the monkey ovary throughout the menstrual cycle
22. Extrapolating rational drug doses and treatment by allometric scaling
23. Fluorescence spectroscopy: A technique with potential to improve the early detection of aerodigestive tract neoplasia
24. Large animal models of human disease
25. Immunohistochemical analysis of the microanatomy of primate ovary
26. Tumor oxygenation: A matter of supply and demand
27. Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy